IFG Advisory’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
JFG
IFG Advisory's XBI Position: Q2 2026 in Review
IFG Advisory opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 3,377 shares worth $534K. The stake represents 0.02% of the portfolio and ranks #589 among its holdings. This is a return to the name: IFG Advisory previously reported a position in XBI as recently as Q4 2024.
IFG Advisory first reported a position in XBI in Q3 2022 and has held it in 4 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- IFG Advisory held 3,377 shares of State Street SPDR S&P Biotech ETF worth $534K as of Q2 2026.
- State Street SPDR S&P Biotech ETF was a new IFG Advisory position in Q2 2026.
- State Street SPDR S&P Biotech ETF made up 0.02% of IFG Advisory's portfolio in Q2 2026, its #589 holding.
- IFG Advisory first reported a position in State Street SPDR S&P Biotech ETF in Q3 2022 and has held it in 4 quarters since.
- 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on IFG Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.